{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:32:08Z","timestamp":1795159928571,"version":"4.10.3"},"reference-count":20,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T00:00:00Z","timestamp":1133222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2006,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>K immunisation is observed in some polytransfused patients and pregnant women but does not occur in all cases of K incompatibility. This study analysed the role of genetic background in this selective response to K antigen by investigating <jats:italic>HLA\u2010DRB1<\/jats:italic> alleles associated with K immunisation in a southern European population. <jats:italic>HLA\u2010DRB1<\/jats:italic> genotyping was performed by polymerase chain reaction sequence\u2010specific oligonucleotide\/sequence\u2010specific primer procedures in 54\u2003K immunised patients and 200 healthy controls. The frequency of <jats:italic>HLA\u2010DRB1<\/jats:italic>*11 was significantly higher in K immunised patients than healthy controls: 31 of 54 (57%) vs. 56 of 200 (28%) (<jats:italic>P<\/jats:italic><jats:sub>c<\/jats:sub>\u2003&lt;\u20030\u00b7001). In the remaining K immunised <jats:italic>HLA\u2010DRB1<\/jats:italic>*11\u2010negative patients, the frequency of <jats:italic>HLA\u2010DRB1<\/jats:italic>*13 was increased: 14 of 23 (61%) vs. 49 of 144 in healthy controls (34%) (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b702). The combined frequency of the two <jats:italic>HLA\u2010DRB1<\/jats:italic> alleles (<jats:italic>HLA\u2010DRB1<\/jats:italic>*11 and <jats:italic>HLA\u2010DRB1<\/jats:italic>*13) was 83% in K immunised patients when compared with 52% in healthy controls (<jats:italic>P<\/jats:italic><jats:sub>c<\/jats:sub>\u2003&lt;\u20030\u00b7001). K and k differ by a single amino acid T193 (M). The DRB1*11 and DRB1*13 alleles share a <jats:italic>HLA\u2010DRB1<\/jats:italic> gene sequence containing S in position 13, D in 70 and A in 74, and coding for the P4 pocket within the HLA\u2010DR binding groove. This feature of the <jats:italic>HLA\u2010DRB1<\/jats:italic> gene could be involved in the K peptide presentation through a polymorphism ligand specific for the T193 (M) of K. In conclusion, this study demonstrated a high frequency of <jats:italic>HLA\u2010DRB1<\/jats:italic>*11 or <jats:italic>HLA\u2010DRB1<\/jats:italic>*13 alleles in K immunised patients, which could be due to specific K peptide presentation by HLA\u2010DR molecules.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05868.x","type":"journal-article","created":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T15:23:05Z","timestamp":1133277785000},"page":"374-378","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["HLA\u2010DRB1 polymorphism is associated with Kell immunisation"],"prefix":"10.1111","volume":"132","author":[{"given":"Jacques","family":"Chiaroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Dettori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Ferrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mhammed","family":"Touinssi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"de Micco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Reviron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,11,29]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2412"},{"key":"e_1_2_7_3_1","volume-title":"Twelfth International Histocompatibility Workshop Reference Protocol Addendum. Technical Handbook","author":"Bignon J.D.","year":"1996"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1991.tb00010.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.3.915"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb13266.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1955.tb01285.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19960915)45:6<795::AID-JNR16>3.0.CO;2-V"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(92)90036-M"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.12.5655"},{"key":"e_1_2_7_11_1","volume-title":"Blood Transfusion In Clinical Medicine","author":"Mollison P.L.","year":"1997"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1992.tb01940.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V8.11.1029.1029"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200103)44:3<535::AID-ANR101>3.0.CO;2-Z"},{"key":"e_1_2_7_15_1","first-page":"175","article-title":"Incidence and persistence of anti\u2010Kell after transfusion of Kell\u2010positive blood","volume":"32","author":"Schabel A.","year":"1994","journal-title":"Beitr Infusionsther Transfusionsmed"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02703770"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/368215a0"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.13.4011"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(94)90477-4"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290011949"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.25.11935"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05868.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05868.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T05:12:37Z","timestamp":1748236357000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05868.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,29]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05868.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05868.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,29]]},"assertion":[{"value":"2005-11-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}